Published on
May 8, 2025
- 20:05 GMT
Caribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business Update
-- Two robust clinical datasets from CB-010 and CB-011 expected to be disclosed in H2 2025 -- -- $212.5 million in cash, cash equivalents, and marketable securities expected to fund the Company’s current operating plan into H2 2027 -- BERKELEY, Calif., May …
Distribution channels:
Business & Economy
...
